The aim of the present work was to identify normal levels of pathologically altered neurons and the intensity of neuron-glial interactions in interconnected parts of the mesoaccumbocingulate dopaminergic system (MDS) of the brain in adult intact female Wistar rats (n = 6) and healthy humans aged 24–45 years (n = 5). The proportions of unaltered, hypochromic, pyknomorphic, and ghost neurons were identified in the anteromedial segment of the paranigral nucleus of the ventral tegmental area (VTA) and the compact zone of the substantia nigra, in the central medial part of the nucleus accumbens (NA) close to the anterior commissure of the brain, and the central part of layer III of the pregenual part of field 24b (Cg3 in rats). Controls consisted of brain formations which are not part of the MDS, i.e., layers III and V of field 1. Our data provide evidence of significant changes in MDS neurons in healthy people as compared with the level of changes in intact rats. The number of pathologically altered MDS neurons in humans decreased with increases in the distance from the catecholaminergic nuclei of the reticular formation, as did the number of fibers in the medial forebrain bundle, reaching a minimum in the non-dopaminoceptive and low-noradrenalinoceptive layer V of field 1. In the VTA, more than 25% of neurons were ghost cells. More than 30% of NA neurons were hypochromic and ghosted. About 25% of neurons in field 24b were ghost cells, hypochromic, and pyknomorphic. The intensities of neuron-glial interactions in the dopaminergic nuclei in humans and intact rats were significantly greater than in the projection areas of the MDS and the non-MDS layers of field 1. Local changes in human MDS neurons and the high intensity of neuron-glial interactions in the dopaminergic nuclei reflect blurring of the boundaries between normal conditions and pathology and the lower durability of this system as compared with cortical fields distant from the origin of catecholaminergic fibers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
I. P. Anokhina, Yu. L. Arzumanov, A. G. Veretinskaya, et al., “Diagnosis of genetic predisposition to psychoactive substance dependence,” in: Questions in the Diagnosis and Treatment of Alcoholism and Drug Addiction [in Russian], Anakharsis, Moscow (2001), pp. 6–29.
V. V. Afanasiev, L. T. Rubitel, and A. V. Afanasiev, Acute Ethyl Alcohol Intoxication [in Russian], Intermedika, St. Petersburg (2002).
V. M. Vostrikov, The Oligodendroglia in the Human Brain in Schizophrenia and Affective Disorders [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (2008).
O. V. Dolzhanskii, Forensic Medical Assessment of Morphological Changes in the Brain in Chronic Opioid Addiction [in Russian], Author’s Abstract of Master’s Thesis in Medical Sciences, Moscow (2001).
A. V. Droblenkov and N. R. Karelina, “Structural characteristics of neurons and macrogliocytes in interconnected areas of the mesoaccumbocingulate dopaminergic system in rats,” Morfologiya, 136, No. 5, 11–17 (2009).
Yu. M. Zhabotinskii, Normal and Pathological Morphology of Neurons [in Russian], Nauka, Moscow (1965).
G. F. Lakin, Biometrics. Textbook for Biological Specialists at Higher Educational Institutions [in Russian], Vysshaya Shkola, Moscow (1980).
L. B. Numand and M. Ya. Otter, “Reactions of the body to barbiturates and the activity of monoaminergic processes in the brain,” Farmakol. Toksikol., No. 3, 23–25 (1983).
L. Z. Pevzner, Functional Biochemistry of the Neuroglia [in Russian], Nauka, Leningrad (1972).
V. B. Pisarev, A. N. Bannov, and O. V. Dolzhanskii, “Morphofunctional characteristics of the median thalamic center in rats in conditions of emotional stress,” in: Morphology of Compensatory and Adaptive Processes in Different Adaptive States [in Russian], Volgograd Medical Academy Press, Volgograd (1998), Vol. 54, Iss. 2, pp. 97–122.
N. A. Uranova, The Dopaminergic System of the Brain in Schizophrenia (an ultrastructural morphometric study) [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (1995).
G. P. Chrousos and P. W. Gold, “The concepts of stress system disorders: overview of behavioral and physical homeostasis,” J. Am. Med. Inform. Assoc., 267, 1244–1252 (1992).
A. Bjorklund and O. Lindvall, “Dopamine-containing systems in the CNS,” in: Handbook of Neuroanatomy, Elsevier Science Publishers, Amsterdam, New York, Oxford (1984), Vol. 2: Classical Neurotransmitters in the CNS, Part 1, pp. 55–122.
R. M. Brown, A. M. Crane, and P. S. Goldman, “Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates,” Brain Res., 168, 133–150 (1979).
X. Dai, L. D. Lercher, P. M. Clinton, et al., “The trophic role of oligodendrocytes in the basal forebrain,” J. Neurosci., 23, No. 13, 5846–5853 (2003).
S. R. George, T. Fan, G. Y. Ng, et al., “Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine,” J. Pharmacol. Exp. Ther., 273, 373–379 (1995).
R. Hassler, “Zur Normalenanatomie der Substantia nigra,” J. Psychol. Neurol., 48, No. 1–2, 1–55 (1937).
H. Hyden, “Behavior, neural function and RNA,” Prog. Nucl. Acid. Res. Mol. Biol., 6, 187–218 (1967).
G. F. Koob, “Drugs of abuse: anatomy, pharmacology and function of reward pathways,” Trends Pharmacol. Sci., 13, No. 5, 177–180 (1992).
M. Le Moal and H. Simon, “Mesocorticolimbic dopamine network: functional and regulatory roles,” Physiol. Rev., 71, 155–234 (1991).
W. J. McBride, J. M. Murphy, L. Lumeng, and T. K. Li, “Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats,” Alcohol, 7, No. 3, 199–205 (1990).
R. S. Oads and G. M. Halliday, “Ventral tegmental system: neurobiology. I. Anatomy and connectivity,” Brain Res. Rev., 12, 117–165 (1987).
J. G. Richards, “Ultrastructural effects of 6-hydroxydopamine on catecholamine containing neurons in the rat brain,” in: 6-Hydroxydopamine and Catecholamine Neurons, North-Holland Publishers, Amsterdam (1971), pp. 151–161.
Z. L. Rossetti, Y. Hmaidan, and G. L. Gessa, “Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats,” Eur. J. Pharmacol., 221, No. 2–3, 227–234 (1992).
P. D. Shabanov, A. A. Lebedev, A. V. Droblenkov, and A. V. Lubimov, “Delayed behavioral and morphological subsequences of activation of the stress-antistress system in early ontogeny in rats,” Int. J. Neuropsychopharmacol., 11, Supplement 1, 208 (2008).
O. Steward, Functional Neuroscience, Springer, New York (2000).
R. A. Wise and P. P. Rompre, “Brain dopamine and reward,” Ann. Rev. Psychol., 40, 191–225 (1989).
Author information
Authors and Affiliations
Additional information
Translated from Morfologiya, Vol. 137, No. 3, pp. 11–17, May–June, 2010.
Rights and permissions
About this article
Cite this article
Droblenkov, A.V. Pathological Changes in Neurons of the Mesocorticolimbic Dopaminergic System in Healthy Humans and Rats. Neurosci Behav Physi 41, 578–585 (2011). https://doi.org/10.1007/s11055-011-9458-x
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-011-9458-x